Utah Growth Study: growth standards and the prevalence of growth hormone deficiency.
about
Aromatase inhibitors for short stature in male children and adolescentsAromatase inhibitors for short stature in male children and adolescentsControversies in the definition and treatment of idiopathic short stature (ISS)Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3Early recognition of growth abnormalities permitting early interventionRole of intensive training in the growth and maturation of artistic gymnastsChallenges in the Diagnosis and Management of Growth Hormone Deficiency in IndiaSOX3 is required during the formation of the hypothalamo-pituitary axisClinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive reviewEffect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical dataDetermining the normal range for IGF-I, IGFBP-3, and ALS: new reference data based on current internal standards.Incidence and prevalence rate estimation of GH treatment exposure in Piedmont pediatric population in the years 2002-2004: Data from the GH Registry.Referral patterns of children with poor growth in primary health care.The diagnostic work up of growth failure in secondary health care; an evaluation of consensus guidelinesGenetic regulation of pituitary gland development in human and mousePriority target conditions for algorithms for monitoring children's growth: Interdisciplinary consensusEtiological factors of short stature in children and adolescents: experience at a tertiary care hospital in Egypt.Pituitary stalk interruption syndrome: diagnostic delay and sensitivity of the auxological criteria of the growth hormone research societyUnderstanding burden of illness for child growth hormone deficiency.Sex-based prevalence of growth faltering in an urban pediatric population.To determine frequency of etiological factors in short statured patients presenting at an endocrine clinic of a tertiary care hospital.Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology.Skeletal age in idiopathic short stature: An analytical study by the TW3 method, Greulich and Pyle methodWhole exome sequencing to identify genetic causes of short statureSex differences in patients referred for evaluation of poor growth.Genetic evaluation of short stature.Autosomal-dominant isolated growth hormone deficiency (IGHD type II) with normal GH-1 gene.Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System.The prevalence of growth hormone deficiency and celiac disease in short children.Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency.Growth monitoring.Uk audit of childhood growth hormone prescription, 1998.Etiologies and characteristics of children with chief complaint of short stature.The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance.Growth response of Egyptian children with idiopathic short stature during four years of growth hormone therapy.Diagnosis of growth hormone deficiency in childhood.Growth hormone deficiency in Sturge-Weber syndrome.Gender Bias in U.S. Pediatric Growth Hormone Treatment.Gender of pediatric recombinant human growth hormone recipients in the United States and globally.The role of transcription factors implicated in anterior pituitary development in the aetiology of congenital hypopituitarism.
P2860
Q24186574-4F38E3B4-2FA7-4E5B-B955-06FBB558D4A3Q24202097-3C0A9DB9-4722-4439-BEF2-3826B950DA24Q24626074-B3138893-679C-4D71-9118-5D1F8779121DQ24674814-7C5D013D-DCEF-46B4-99BE-E2EC21230FDDQ26827111-4ADADBC1-4445-45F6-9872-B5D22F567565Q27013916-D707BE70-AD5B-4822-8DF6-87B74DE9F0C1Q28076439-9A218FCE-3163-4646-BFCD-8B47E88E5E4FQ28587871-019F794B-81E3-423B-8F10-6DFBC54EF0D9Q30353128-51E656B3-E554-4A09-ABE7-C1F81F2A6B5AQ30726620-C72DFFDF-3821-463D-A100-7C4CBB17D871Q30847393-F3171962-DFDB-45ED-AB77-873B1D663F14Q31046022-77AAACD8-17D3-455A-BB6F-6D8BC87E763FQ33284275-4BBD97CA-7941-4535-B63D-A57C8689675EQ33334216-8AE0150A-94C6-491B-B720-521A2C6A6249Q33590141-CA265CEC-E7D3-4849-98DE-FAA4DCECC191Q33610435-5169B68C-EB97-491F-8616-4274C3BADD7DQ33788096-DDA60572-D3D8-4DB6-982B-9ACC618E4DF4Q33813144-072328D7-3BBB-4040-8180-291AC1766151Q33841801-A1B6548C-81C4-4AE3-AF8E-2081F33702B7Q33968143-23DEBA27-5902-409B-88B0-1606D2535ACFQ34002009-EC700B06-948F-4B4A-81C5-2EE4EB1D73D5Q34009361-829F3AC0-9500-4BAF-9270-3196D33F5FC9Q34027730-11547A9C-8144-4042-B599-4CF0773BA125Q34033624-6042DD34-D316-4C8A-A11B-8EC64327DB74Q34102453-83E05848-E627-4C96-9581-1085828234E3Q34130975-87EADABB-07AD-4687-A9D1-DC601BF70D6AQ34486313-A7D0E2BE-1852-4FBC-B154-05A64DCE5584Q34627035-88C26118-0A11-422F-80E2-0279FC45054AQ35040137-D1917F9C-1AC3-4E3D-97E3-0E49E74DF453Q35263119-3F12263C-C4F7-494F-8058-23A54170E5FBQ35265594-1E2ED2E8-9BA8-437B-A593-9CE01AABA4C2Q35269869-079C278D-216B-45F2-91A4-9F291E47BEDAQ35419700-91B4FE8B-F627-43A6-A4E9-72BB1D3AB93FQ35737624-E769866B-28E0-4A94-98F2-F3EA03C74EE8Q35749319-B3F6BAAE-85EF-44F6-B830-EDF477C57A23Q35758276-1FBF0FDC-D73F-443E-BCCD-0CE4D26C36ABQ36121223-A60E751F-7B8D-4214-B360-C9CBA1FEF873Q36293471-07D0D9BD-4608-4346-A115-A7C5BAC793A7Q36732668-6999A6C5-D3EC-446A-8B09-2A937DD3D774Q36793669-4E3EAA03-9446-492D-B40E-ADBFB87BE48C
P2860
Utah Growth Study: growth standards and the prevalence of growth hormone deficiency.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Utah Growth Study: growth standards and the prevalence of growth hormone deficiency.
@en
Utah Growth Study: growth standards and the prevalence of growth hormone deficiency.
@nl
type
label
Utah Growth Study: growth standards and the prevalence of growth hormone deficiency.
@en
Utah Growth Study: growth standards and the prevalence of growth hormone deficiency.
@nl
prefLabel
Utah Growth Study: growth standards and the prevalence of growth hormone deficiency.
@en
Utah Growth Study: growth standards and the prevalence of growth hormone deficiency.
@nl
P2093
P1476
Utah Growth Study: growth standards and the prevalence of growth hormone deficiency.
@en
P2093
P356
10.1016/S0022-3476(94)70117-2
P407
P577
1994-07-01T00:00:00Z